Male birth control pill enters human trials
Disease control
Recruiting now
This study tests a new daily pill, YCT-529, as a form of male contraception. It involves 88 healthy men aged 28 to 70 who either plan to have a vasectomy or have decided not to have children. The main goal is to check the pill's safety and side effects over 28, 90, or 180 days.
Phase: PHASE1, PHASE2 • Sponsor: YourChoice Therapeutics, Inc. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC